PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.55%
Revenue growth at 50-75% of ADI's 16.61%. Martin Whitman would worry about competitiveness or product relevance.
10.73%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
18.30%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
18.21%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
5.92%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
6.06%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
6.19%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.40%
Share reduction while ADI is at 10.53%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.39%
Reduced diluted shares while ADI is at 10.41%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
15.35%
OCF growth under 50% of ADI's 65.81%. Michael Burry might suspect questionable revenue recognition or rising costs.
14.67%
FCF growth under 50% of ADI's 65.83%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
55.93%
10Y revenue/share CAGR at 75-90% of ADI's 65.87%. Bill Ackman would press for new markets or product lines to narrow the gap.
27.00%
5Y revenue/share CAGR at 50-75% of ADI's 48.53%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.87%
3Y revenue/share CAGR under 50% of ADI's 51.81%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
47.63%
10Y OCF/share CAGR under 50% of ADI's 111.27%. Michael Burry would worry about a persistent underperformance in cash creation.
55.81%
5Y OCF/share CAGR at 50-75% of ADI's 101.57%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
27.49%
3Y OCF/share CAGR under 50% of ADI's 100.88%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
150.27%
Positive 10Y CAGR while ADI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
171.55%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
66.59%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
34.68%
Below 50% of ADI's 214.45%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.06%
Below 50% of ADI's 121.79%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.24%
Below 50% of ADI's 85.62%. Michael Burry suspects a serious short-term disadvantage in building book value.
526.04%
10Y dividend/share CAGR above 1.5x ADI's 126.13%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
192.90%
5Y dividend/share CAGR above 1.5x ADI's 36.11%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.12%
3Y dividend/share CAGR above 1.5x ADI's 10.50%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
9.87%
AR growth is negative/stable vs. ADI's 33.40%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
5.64%
Inventory shrinking or stable vs. ADI's 77.21%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.88%
Asset growth well under 50% of ADI's 160.92%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.05%
Under 50% of ADI's 69.92%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
6.70%
Debt shrinking faster vs. ADI's 238.82%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
2.44%
R&D dropping or stable vs. ADI's 27.88%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.14%
We cut SG&A while ADI invests at 45.94%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.